Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

FLAC

Frazier LifeSciences Acq... (FLAC)

Frazier LifeSciences Acquisition Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FLAC
DateTimeSourceHeadlineSymbolCompany
16/02/202302:15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
03/12/202208:32Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
02/12/202208:52Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
26/11/202205:44Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
24/11/202208:37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
24/11/202208:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
24/11/202208:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
24/11/202208:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
24/11/202208:27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
24/11/202200:00GlobeNewswire Inc.NewAmsterdam Pharma Debuts as Publicly Traded Company Focused on Developing Obicetrapib, a Low-Dose, Once-Daily Oral LDL-Lowering Agent with Promising Safety and Efficacy Clinical Data, as a Potential Preferred Therapy for High Risk Cardiovascular DiseaseNASDAQ:FLACFrazier LifeSciences Acquisition Corporation
23/11/202208:17Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
23/11/202208:16Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
16/11/202203:31Business WireFrazier Lifesciences Acquisition Corporation Shareholders Approve Business Combination with NewAmsterdam Pharma Holding B.V.NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
15/11/202210:13Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
10/11/202208:07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
05/11/202209:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
14/10/202208:02Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
06/10/202207:17Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
05/10/202207:17Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
29/09/202207:31Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
26/09/202222:00GlobeNewswire Inc.Phathom Pharmaceuticals Appoints Dr. James Topper to its Board of DirectorsNASDAQ:FLACFrazier LifeSciences Acquisition Corporation
24/09/202206:17Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
21/09/202206:31Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
20/09/202220:07Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
30/08/202206:16Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
25/08/202207:04Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
20/08/202207:01Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
18/08/202206:32Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
17/08/202207:07Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
12/08/202207:28Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FLACFrazier LifeSciences Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:FLAC